Form D · Biotechnology

ReCor Medical, Inc.

Palo Alto, CA · CIK 0001676839

Offering snapshot reported Aug 15, 2017 · SEC filing

Reported sold
$22M
Offering amount: $22M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 12, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11M$22MJun 10, 2016: $10,000,000.00Jun 10, 2016Aug 15, 2017: $22,000,000.00Aug 15, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,000,000 → $22,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 15, 2017Amendment$22,000,000$12,000,000vs Jun 10, 20161SEC filing
Jun 10, 2016Initial$10,000,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-264808

Source: Form D, filed Aug 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kazumichi Kobayashi Director
Frank Litvack Director
Antoine Papiernik Director, Executive
Jacques Seguin Director
Martin J. Waters Executive
F. Thomas Watkins Director
Andrew M. Weiss Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1049 Elwell Court
Palo Alto, CA, 94303